CapsoVision (CV) vs Standard BioTools (LAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CapsoVision (CV) has outperformed Standard BioTools (LAB) over the past year, gaining 38.9% versus a loss of 47.8%. CapsoVision is the larger company by market cap ($348.0 million vs $266.4 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | LAB |
|---|---|---|
| Share price | $6.54 | $0.6787 |
| Market cap | $348.00M | $266.44M |
| 1-day change | +0.62% | -6.00% |
| YTD return | -38.82% | -46.98% |
| 1-year return | +38.85% | -47.79% |
| 5-year return | — | -87.29% |
| EPS (TTM) | $-0.45 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.37 | $1.72 |
| 52-week low | $4.38 | $0.63 |
| Distance from 52-week high | -57.45% | -60.54% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +45.26% | +98.91% |
| Average volume | 158.95K | 1.57M |
| Shares outstanding | 53.21M | 392.58M |
| Employees | 99 | 385 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CV has outperformed LAB by 86.6 percentage points over the past year.
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Healthcare · Medical Devices · 99 employees
About Standard BioTools
LAB stock →Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.
Healthcare · Medical Devices · 385 employees
CV vs LAB FAQ
Which is bigger, CapsoVision or Standard BioTools?
CapsoVision (CV) is larger, with a market capitalization of $348.00M compared with $266.44M for Standard BioTools (LAB).
Which stock has performed better over the past year, CV or LAB?
CV returned +38.85% over the past 12 months, compared with -47.79% for LAB (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and Standard BioTools in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.